Archives
-
PerspectiveDecember 31, 2021
0
2311
527
Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy
Chantana Polprasert, M.D., Kitsada Wudhikarn, M.D., Ponlapat Rojnuckarin, M.D., Ph.D.
Blood Res 2021; 56(4): 209-211 -
PerspectiveDecember 31, 2021
1
2484
360
Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1 nCoV-19
Hee Ryeong Jang, M.D., Kyu-Hyoung Lim, M.D., Ph.D.
Blood Res 2021; 56(4): 212-214 -
Review ArticleDecember 31, 2021
7
2202
608
Effects and treatment applications of polymeric nanoparticles on improving platelets' storage time: a review of the literature from 2010 to 2020
Tahereh Zadeh Mehrizi, Sedigheh Amini Kafiabad, Peyman Eshghi
Blood Res 2021; 56(4): 215-228 -
Review ArticleDecember 31, 2021
21
5590
1028
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
Blood Res 2021; 56(4): 229-242 -
Original ArticleDecember 31, 2021
4
3260
685
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, Kwai Han Yoo, Chul Won Jung, Dae Sik Kim, Jeong-Ok Lee, Hyeon Seok Eom, Ja Min Byun, Youngil Koh, Sung Soo Yoon, Jin Seok Kim, Jee Hyun Kong, Ho-Young Yhim, Deok-Hwan Yang, Dok Hyun Yoon, Do Hyoung Lim, Won-Sik Lee, Ho-Jin Shin
Blood Res 2021; 56(4): 243-251 -
Original ArticleDecember 31, 2021
4
3336
635
Mutation analysis and characterisation of F9 gene in haemophilia- B population of India
Sujayendra Kulkarni, Rajat Hegde, Smita Hegde, Suyamindra S. Kulkarni, Suresh Hanagvadi, Kusal K. Das, Sanjeev Kolagi, Pramod B. Gai, Rudragouda Bulagouda
Blood Res 2021; 56(4): 252-258 -
Original ArticleDecember 31, 2021
14
6736
772
Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
A-Jin Lee, Sang-Gyung Kim, Jun Yeb Nam, Jaehum Yun, Hun-Mo Ryoo, Sung Hwa Bae
Blood Res 2021; 56(4): 259-265 -
Original ArticleDecember 31, 2021
1
2828
560
Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
Joon Young Hur, Sang Eun Yoon, Darae Kim, Jin-oh Choi, Ju-Hong Min, Byung Jun Kim, Jung Sun Kim, Jung Eun Lee, Joon Young Choi, Eun-Seok Jeon, Seok Jin Kim, Kihyun Kim
Blood Res 2021; 56(4): 266-278 -
Original ArticleDecember 31, 2021
1
2698
596
Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
Mohammad Ma’koseh, Rula Amarin, Faris Tamimi, Baha’ Sharaf, Alaa Abufara, Omar Shahin, Mohammed K. M. Manassra, Khalid Halahleh
Blood Res 2021; 56(4): 279-284 -
Original ArticleDecember 31, 2021
3
4115
724
R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
Ji Yun Lee, Jin Ho Paik, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee
Blood Res 2021; 56(4): 285-292
